Valuation: Bayer AG

Market Cap 38.89B 44.18B 35.88B 33.55B 62.87B 4,164B 64.04B 431B 167B 2,054B 166B 162B 7,147B P/E 2026 *
16.8x
P/E 2027 * 12.7x
Enterprise Value 70.57B 80.16B 65.09B 60.88B 114B 7,556B 116B 782B 303B 3,727B 301B 294B 12,967B EV / Sales 2026 *
1.55x
EV / Sales 2027 * 1.44x
Free-Float
100%
Yield 2026 *
0.58%
Yield 2027 * 1.59%
1 day+3.26%
1 week+5.47%
Current month+9.40%
1 month+3.88%
3 months+4.76%
6 months+11.28%
Current year+7.91%
1 week 36.98
Extreme 36.98
40.2
1 month 33.07
Extreme 33.07
40.2
Current year 33.07
Extreme 33.07
49.76
1 year 24.89
Extreme 24.89
49.76
3 years 18.5
Extreme 18.5
53.68
5 years 18.5
Extreme 18.5
67.95
10 years 18.5
Extreme 18.5
123.82
Manager TitleAgeSince
Chief Executive Officer 59 2023-05-31
Director of Finance/CFO 57 2026-05-31
Chief Tech/Sci/R&D Officer 59 2021-01-31
Director TitleAgeSince
Director/Board Member 56 2012-03-31
Director/Board Member 66 2022-03-31
Director/Board Member 60 2017-03-31
Change 5-day change 1-year change 3-year change Capi.($)
+3.26%+5.47% - - 43.17B
+0.92%+0.47%+43.59%+143.50% 987B
+0.80%+2.90%+58.35%+45.64% 576B
+0.06%+6.17%+26.59%+72.81% 415B
+0.25%-2.44%+22.01%+15.66% 320B
+2.35%+3.25%+34.63%+21.78% 278B
+0.75%+2.76%+30.31%+37.10% 279B
+1.23%+9.11%-31.23%-42.75% 208B
+1.27%+2.86%+26.65%+54.74% 187B
+0.09%-0.23%+16.75%+61.56% 155B
Average +1.09%+2.79%+25.30%+45.56% 378.36B
Weighted average by Cap. +0.86%+2.25%+33.45%+67.69%

Financials

2026 *2027 *
Net sales 45.54B 51.73B 42.01B 39.29B 73.61B 4,876B 74.98B 505B 196B 2,405B 194B 190B 8,368B 46.68B 53.02B 43.06B 40.27B 75.45B 4,998B 76.86B 517B 200B 2,465B 199B 195B 8,577B
Net income 2.17B 2.47B 2B 1.87B 3.51B 232B 3.58B 24.07B 9.32B 115B 9.26B 9.06B 399B 2.96B 3.36B 2.73B 2.55B 4.79B 317B 4.88B 32.83B 12.71B 156B 12.63B 12.36B 544B
Net Debt 31.68B 35.98B 29.22B 27.33B 51.2B 3,392B 52.16B 351B 136B 1,673B 135B 132B 5,821B 28.55B 32.43B 26.34B 24.63B 46.15B 3,057B 47.02B 317B 123B 1,508B 122B 119B 5,247B
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
87,757
Date Price Change Volume
26-06-24 €39.84 +3.08% 21,746
26-06-23 €38.65 +1.74% 5,880
26-06-22 €37.99 +0.48% 12,649
26-06-19 €37.81 +1.80% 1,779
26-06-18 €37.14 -1.85% 4,328
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
39.59EUR
Average target price
50.58EUR
Spread / Average Target
+27.77%

Quarterly revenue - Rate of surprise